670
Views
15
CrossRef citations to date
0
Altmetric
Review Article

A review and critique of U.S. EPA's risk assessments for asbestos

, , , , &
Pages 499-522 | Received 17 Sep 2013, Accepted 05 Mar 2014, Published online: 07 May 2014

References

  • Aguilar-Madrid G, Robles-Perez E, Juarez-Perez CA, Alvarado-Cabrero I, Rico-Mendez FG, Javier KG. (2010). Case-control study of pleural mesothelioma in workers with social security in Mexico. Am J Ind Med, 53, 241–51.
  • Albert RE, Train RE, Anderson E. (1977). Rationale developed by the Environmental Protection Agency for the assessment of carcinogenic risks. J Natl Cancer Inst, 58, 1537–41.
  • Amandus HE, Althouse R, Morgan WK, Sargent EN, Jones R. (1987b). The morbidity and mortality of vermiculite miners and millers exposed to tremolite-actinolite: Part III. Radiographic findings. Am J Ind Med, 11, 27–37.
  • Amandus HE, Wheeler R. (1987a). The morbidity and mortality of vermiculite miners and millers exposed to tremolite-actinolite: Part II. Mortality. Am J Ind Med, 11:15–26
  • American Thoracic Society (ATS). (2004). Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med, 170, 691–715.
  • Andrion A, Pira E, Mollo F. (1984). Pleural plaques at autopsy, smoking habits, and asbestos exposure. Eur J Respir Dis, 65, 125–30.
  • Armitage P, Doll R. (1954). The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer, 8, 1–12.
  • ATSDR. (September 2001). Toxicological Profile for Asbestos. CAS #: 1332-21-4. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Services, Agency for Toxic Substances and Disease Registry (ATSDR).
  • Bateson TF, Kopylev L. (2014). Influence of exposure assessment and parameterization on exposure response. Aspects of epidemiologic cohort analysis using the Libby Amphibole asbestos worker cohort. J Expo Sci Environ Epidemiol.
  • Berman DW, Case BW. (2012). Overreliance on a single study: there is no real evidence that applying quality criteria to exposure in asbestos epidemiology affects the estimated risk. Ann Occup Hyg, 56, 869–78.
  • Berman DW, Case BW. (2013). Quality of evidence must guide risk assessment of asbestos, by Lenters, V; Burdorf, A; Vermeulen, R; Stayner, L; Heederik, D. Ann Occup Hyg, 57, 667–9.
  • Berman DW, Crump KS. (2008a). Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol, 38, 1–47.
  • Berman DW, Crump KS. (2008b). A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol, 38, 49–73.
  • Bourbeau J, Ernst P, Chrome J, Armstrong B, Becklake MR. (1990). The relationship between respiratory impairment and asbestos-related pleural abnormality in an active work force. Am Rev Respir Dis, 142, 837–42.
  • Broderick A, Fuortes LJ, Merchant JA, Galvin JR, Schwartz DA. (1992). Pleural determinants of restrictive lung function and respiratory symptoms in an asbestos-exposed population. Chest, 101, 684–91.
  • BTS. (2011). Pleural plaques. Information for health care professionals. London: British Thoracic Society (BTS).
  • Budtz-Jorgensen E, Bellinger D, Lanphear B, Grandjean P, International Pooled Lead Study Investigators. (2013). An international pooled analysis for obtaining a benchmark dose for environmental lead exposure in children. Risk Anal, 33, 450–61.
  • Bussard D. (2012). Memorandum from David Bussard, Director, Washington Division, National Center for Environment Assessment, U.S. Environmental Protection Agency, to Diana Wong, Ph.D., Designated Federal Officer, Science Advisory Board, U.S. EPA. Subject: References Requested by the SAB Review Panel for the peer review of the Draft Toxicological Review of Libby Amphibole Asbestos. 6 February 2012. Available at: http://www.yosemite.epa.gov/sab/sabproduct.nsf/1DE881CF85B748C18525799D004D5278/$File/SAB_LiteratureRequest_EPA_6Feb2012_pub.pdf. Last accessed: January 21, 2014.
  • Christensen KY, Kopylev L. (2012). Localized pleural thickening: smoking and exposure to Libby vermiculite. J Expo Sci Environ Epidemiol, 22, 320–3.
  • Clarke CC, Mowat FS, Kelsh MA, Roberts MA. (2006). Pleural plaques: a review of diagnostic issues and possible nonasbestos factors. Arch Environ Occup Health, 61, 183–92.
  • Clin B, Paris C, Ameille J, Brochard P, Conso F, Gislard A, et al. (2011). Do asbestos-related pleural plaques on HRCT scans cause restrictive impairment in the absence of pulmonary fibrosis?Thorax, 66, 985–91.
  • Copley SJ, Wells AU, Rubens MB, Chabat F, Sheehan RE, Musk AW, Hansell DM. (2001). Functional consequences of pleural disease evaluated with chest radiography and CT. Radiology, 220, 237–43.
  • Cox DR. (1972). Regression models and life-tables. J Roy Stat Soc Ser B, 34, 187–220.
  • Crump KS. (1984). A new method for determining allowable daily intakes. Fundam Appl Toxicol, 4, 854–71.
  • Crump KS, Van Landingham C, Shamlaye C, Cox C, Davidson PW, Myers GJ, Clarkson TW. (2000). Benchmark concentrations for methylmercury obtained from the Seychelles Child Development Study. Environ Health Perspect, 108, 257–63.
  • Dave SK, Ghodasara NB, Mohanrao N, Patel GC, Patel BD. (1997). The relation of exposure to asbestos and smoking habit with pulmonary function tests and chest radiograph. Indian J Public Health, 41, 16–24.
  • Davis JA, Gift JS, Zhao QJ. (2011). Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1. Toxicol Appl Pharmacol, 254, 181–91.
  • Delclos GL, Wilson RK, Bradley BL. (1990). Influence of smoking on radiographic profusion and pleural changes in asbestos-exposed subjects. J Occup Med, 32, 577–81.
  • European Commission. (1997). Commission Directive 97/69/EC of 5 December 1997. Off J Eur Communities L, 343, 19–24.
  • Garcia-Closas M, Christiani DC. (1995). Asbestos-related diseases in construction carpenters. Am J Ind Med, 27, 115–25.
  • Glass DC, Sim MR, Fritschi L, Gray CN, Jolley DJ, Gibbons C. (2004). Leukemia risk and relevant benzene exposure period-Re: follow-up time on risk estimates, Am J Ind Med 42:481–489, 2002. Am J Ind Med, 45, 222–3. author reply 24–5.
  • Hazelton WD, Clements MS, Moolgavkar SH. (2005). Multistage carcinogenesis and lung cancer mortality in three cohorts. Cancer Epidemiol Biomarkers Prev, 14, 1171–81.
  • Hein MJ, Stayner LT, Lehman E, Dement JM. (2007). Follow-up study of chrysotile textile workers: cohort mortality and exposure-response. Occup Environ Med, 64, 616–25.
  • Hernan MA. (2010). The hazards of hazard ratios. Epidemiology, 21, 13–5.
  • Hillerdal G. (1983). Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest, 77, 321–43.
  • Hillerdal G. (1994). Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. Chest, 105, 144–50.
  • Hillerdal G. (1997). Pleural plaques: incidence and epidemiology, exposed workers and the general population: a review. Indoor Built Environ, 6, 86–95.
  • Hillerdal G, Henderson DW. (1997). Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health, 23, 93–103.
  • Hodgson JT, Darnton A. (2000). The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg, 44, 565–601.
  • Huncharek M. (2002). Non-asbestos related diffuse malignant mesothelioma. Tumori, 88, 1–9.
  • International Labour Organization (ILO). (2011). Guidelines for the use of the ILO International Classification of Radiographs of Pneumoconioses, revised edition 2011.
  • Jurek AM, Greenland S, Maldonado G, Church TR. (2005). Proper interpretation of non-differential misclassification effects: expectations vs observations. Int J Epidemiol, 34, 680–687.
  • Kilburn KH, Warshaw RH. (1991). Abnormal lung function associated with asbestos disease of the pleura, the lung, and both: a comparative analysis. Thorax, 46, 33–8.
  • Kopylev L, Sullivan PA, Vinikoor LC, Bateson TF. (2011). Monte Carlo analysis of impact of underascertainment of mesothelioma cases on underestimation of risk. Open Epidemiol J, 4, 45–53.
  • Kouris SP, Parker DL, Bender AP, Williams AN. (1991). Effects of asbestos-related pleural disease on pulmonary function. Scand J Work Environ Health, 17, 179–83.
  • Lacourt A, Rolland P, Gramond C, Astoul P, Chamming's S, Ducamp S, et al. (2010). Attributable risk in men in two French case-control studies on mesothelioma and asbestos. Eur J Epidemiol, 25, 799–806.
  • Larson TC, Antao VC, Bove FJ. (2010a). Vermiculite worker mortality: estimated effects of occupational exposure to Libby amphibole. J Occup Environ Med, 52, 555–60.
  • Larson TC, Antao VC, Bove FJ, Cusack C. (2012a). Association between cumulative fiber exposure and respiratory outcomes among Libby vermiculite workers. J Occup Environ Med, 54, 56–63.
  • Larson TC, Lewin M, Gottschall EB, Antao VC, Kapil V, Rose CS. (2012b). Associations between radiographic findings and spirometry in a community exposed to Libby amphibole. Occup Environ Med, 69, 361–6.
  • Larson TC, Meyer CA, Kapil V, Gurney JW, Tarver RD, Black CB, Lockey JE. (2010b). Workers with Libby amphibole exposure: retrospective identification and progression of radiographic changes. Radiology, 255, 924–33.
  • Lenters V, Vermeulen R, Dogger S, Stayner L, Portengen L, Burdorf A, Heederik D. (2011). A meta-analysis of asbestos and lung cancer: is better quality exposure assessment associated with steeper slopes of the exposure-response relationships?Environ Health Perspect, 119, 1547–55.
  • Lewis RW, Billington R, Debryune E, Gamer A, Lang B, Carpanini F. (2002). Recognition of adverse and nonadverse effects in toxicity studies. Toxicol Pathol, 30, 66–74.
  • Lilis R, Miller A, Godbold J, Chan E, Benkert S, Selikoff IJ. (1991a). The effect of asbestos-induced pleural fibrosis on pulmonary function: quantitative evaluation. Ann N Y Acad Sci, 643, 162–8.
  • Lilis R, Miller A, Godbold J, Chan E, Selikoff IJ. (1991b). Radiographic abnormalities in asbestos insulators: effects of duration from onset of exposure and smoking. Relationships of dyspnea with parenchymal and pleural fibrosis. Am J Ind Med, 20, 1–15.
  • Lockey JE, Brooks SM, Jarabek AM, Khoury PR, McKay RT, Carson A, et al. (1984). Pulmonary changes after exposure to vermiculite contaminated with fibrous tremolite. Am Rev Respir Dis, 129, 952–8.
  • Lubin JH, Alavanja MC, Caporaso N, Brown LM, Brownson RC, Field RW, et al. (2007a). Cigarette smoking and cancer risk: modeling total exposure and intensity. Am J Epidemiol, 166, 479–89.
  • Lubin JH, Caporaso N, Wichmann HE, Schaffrath-Rosario A, Alavanja MC. (2007b). Cigarette smoking and lung cancer: modeling effect modification of total exposure and intensity. Epidemiology, 18, 639–48.
  • Lubin JH, Caporaso NE. (2006). Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev, 15, 517–23.
  • Mastrangelo G, Ballarin MN, Bellini E, Bicciato F, Zannol F, Gioffre F, et al. (2009). Asbestos exposure and benign asbestos diseases in 772 formerly exposed workers: dose-response relationships. Am J Ind Med, 52, 596–602.
  • McDonald JC, Harris J, Armstrong B. (2002). Cohort mortality study of vermiculite miners exposed to fibrous tremolite: an update. Ann Occup Hyg, 46, 93–4.
  • McDonald JC, Harris J, Armstrong B. (2004). Mortality in a cohort of vermiculite miners exposed to fibrous amphibole in Libby, Montana. Occup Environ Med, 61, 363–6.
  • McDonald JC, McDonald AD, Armstrong B, Sebastien P. (1986b). Cohort study of mortality of vermiculite miners exposed to tremolite. Br J Ind Med, 43, 436–44.
  • McDonald JC, Sebastien P, Armstrong B. (1986a). Radiological survey of past and present vermiculite miners exposed to tremolite. Br J Ind Med, 43, 445–9.
  • Meza R, Hazelton WD, Colditz GA, Moolgavkar SH. (2008). Analysis of lung cancer incidence in the Nurses’ Health and the Health Professionals’ Follow-Up Studies using a multistage carcinogenesis model. Cancer Causes Control, 19, 317–28.
  • Miller A, Lilis R, Godbold J, Chan E, Wu X, Selikoff IJ. (1994). Spirometric impairments in long-term insulators. Relationships to duration of exposure, smoking, and radiographic abnormalities. Chest, 105, 175–82.
  • Miller JA, Zurlo JV. (1996). Asbestos plaques in a typical Veteran's hospital population. Am J Ind Med, 30, 726–9.
  • Moolgavkar SH. (2014). Multistage carcinogenesis and epidemiologic studies of cancer. In: Almudevar AL, Hall WJ, Oakes D, eds. Modeling and Inference in Biomedical Science - In Memory of Andrei Yakovlev. Institute of Mathematical Statistics Collections Series.
  • Moolgavkar SH, Holford TR, Levy DT, Kong CY, Foy M, Clarke L, et al. (2012). Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975–2000. J Natl Cancer Inst, 104, 541–8.
  • Moolgavkar SH, Meza R, Turim J. (2009). Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005. Cancer Causes Control, 20, 935–44.
  • Moolgavkar SH, Turim J, Alexander DD, Lau EC, Cushing CA. (2010). Potency factors for risk assessment at Libby, Montana. Risk Anal, 30, 1240–8.
  • Muravov OI, Kaye WE, Lewin M, Berkowitz Z, Lybarger JA, Campolucci SS, Parker JE. (2005). The usefulness of computed tomography in detecting asbestos-related pleural abnormalities in people who had indeterminate chest radiographs: the Libby, MT, experience. Int J Hyg Environ Health, 208, 87–99.
  • National Research Council (NRC). (1983). Committee on the Institutional Means for Assessment of Risks to Public Health, Commission on Life Sciences. Risk Assessment in the Federal Government: Managing the Process. Washington, D.C.: National Academy Press.
  • National Research Council (NRC). (2011). Committee to Review EPA's Draft IRIS Assessment of Formaldehyde. Review of the Environmental Protection Agency's Draft IRIS Assessment of Formaldehyde. Washington, D.C.: National Academy Press.
  • Oliver LC, Eisen EA, Greene R, Sprince NL. (1988). Asbestos-related pleural plaques and lung function. Am J Ind Med, 14, 649–56.
  • Pairon JC, Laurent F, Rinaldo M, Clin B, Andujar P, Ameille J, et al. (2013). Pleural plaques and the risk of pleural mesothelioma. J Natl Cancer Inst, 105, 293–301.
  • Paris C, Thierry S, Brochard P, Letourneux M, Schorle E, Stoufflet A, et al. (2009). Pleural plaques and asbestosis: dose- and time-response relationships based on HRCT data. Eur Respir J, 34, 72–9.
  • Pearle JL. (1982). Smoking and duration of asbestos exposure in the production of functional and roentgenographic abnormalities in shipyard workers. J Occup Med, 24, 37–40.
  • Peipins LA, Lewin M, Campolucci S, Lybarger JA, Miller A, Middleton D, et al. (2003). Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA. Environ Health Perspect, 111, 1753–9.
  • Peto J. (2012). That the effects of smoking should be measured in pack-years: misconceptions 4. Br J Cancer, 107, 406–7.
  • Peto J, Seidman H, Selikoff IJ. (1982). Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer, 45, 124–35.
  • Petrovic P, Ostojic L, Peric I, Mise K, Ostojic Z, Bradaric A, et al. (2004). Lung function changes in pleural asbestosis. Coll Antropol, 28, 711–5.
  • Poole C. (2010). On the origin of risk relativism. Epidemiology, 21, 3–9.
  • Price B, Ware A. (2004). Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol, 159, 107–12.
  • Price B, Ware A. (2009). Time trends of mesothelioma incidence in the United States and projection of future cases: An update based on SEER data from 1973 through 2005. Critical Reviews of Toxicology, 39, 576–588.
  • Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J. (2009). Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer, 100, 1175–83.
  • Renwick AG, Barlow SM, Hertz-Picciotto I, Boobis AR, Dybing E, Edler L, et al. (2003). Risk characterisation of chemicals in food and diet. Food Chem Toxicol, 41, 1211–71.
  • Richardson DB. (2008). Temporal variation in the association between benzene and leukemia mortality. Environ Health Perspect, 116, 370–4.
  • Richardson DB. (2009). Lung cancer in chrysotile asbestos workers: analyses based on the two-stage clonal expansion model. Cancer Cause Control, 20, 917–23.
  • Rogan WJ, Gladen BC, Ragan NB, Anderson HA. (1987). US prevalence of occupational pleural thickening. A look at chest X-rays from the first National Health and Nutrition Examination Survey. Am J Epidemiol, 126, 893–900.
  • Rohs AM, Lockey JE, Dunning KK, Shukla R, Fan H, Hilbert T, et al. (2008). Low-level fiber-induced radiographic changes caused by Libby vermiculite: a 25-year follow-up study. Am J Respir Crit Care Med, 177, 630–7.
  • Rosenstock L, Barnhart S, Heyer NJ, Pierson DJ, Hudson LD. (1988). The relation among pulmonary function, chest roentgenographic abnormalities, and smoking status in an asbestos-exposed cohort. Am Rev Respir Dis, 138, 272–7.
  • Schoenfeld DA. (1982). Partial residuals for the proportional hazards regression model. Biometrika, 69, 239–41.
  • Science Advisory Board (SAB) Asbestos Committee. (November 14, 2008).SAB Consultation on EPA's Proposed Approach for Estimation of Bin-Specific Cancer Potency Factors for Inhalation Exposure to Asbestos. EPA-SAB-09-004. Letter to The Honorable Stephen L. Johnson, Administrator, U.S. EPA.
  • Singh B, Eastwood PR, Finucane KE, Panizza JA, Musk AW. (1999). Effect of asbestos-related pleural fibrosis on excursion of the lower chest wall and diaphragm. Am J Respir Crit Care Med, 160, 1507–15.
  • Soulat JM, Lauque D, Esquirol Y, Déprés M, Giron J, Claudel R, Carles P. (1999). High-resolution computed tomography abnormalities in ex-insulators annually exposed to asbestos dust. Am J Ind Med, 36, 593–601.
  • Spirtas R, Heineman EF, Bernstein L, Beebe GW, Keehn RJ, Stark A, et al. (1994). Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med, 51, 804–11.
  • Spyratos D, Chloros D, Haidich B, Dagdilelis L, Markou S, Sichletidis L. (2012). Chest imaging and lung function impairment after long-term occupational exposure to low concentrations of chrysotile. Arch Environ Occup Health, 67, 84–90.
  • Staples CA, Gamsu G, Ray CS, Webb WR. (1989). High resolution computed tomography and lung function in asbestos-exposed workers with normal chest radiographs. Am Rev Respir Dis, 139, 1502–8.
  • Sullivan PA. (2007). Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: update of a cohort mortality study. Environ Health Perspect, 115, 579–85.
  • Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, et al. (2011). Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst, 103, 1058–68.
  • Thomas DC. (1995). When will nondifferential misclassification of an exposure preserve the direction of a trend?Am J Epidemiol, 142, 782–783.
  • Thomas DC. (2014). Invited commentary: is it time to retire the “pack-years” variable? Maybe not!Am J Epidemiol, 179, 299–302.
  • U.S. EPA. (June 1986). Airborne Asbestos Health Assessment Update. EPA/600/8–84/003F. Washington, DC: United States Environmental Protection Agency (U.S. EPA).
  • U.S. EPA. (2012b). Appendix C: Glossary of Terms. Benchmark Dose Software (BMDS) Tutorial. Available at: http://www.epa.gov/ncea/bmds/bmds_training/appendices/glossary.htm. Last updated: 07/31/2012.
  • U.S. EPA. (2013a). Benchmark Dose Software (BMDS). Available at: http://www.epa.gov/ncea/bmds/index.html. Last updated: 04/25/2013.
  • U.S. EPA. (June 2012). Benchmark Dose Technical Guidance. EPA/100/R-12/001. Washington, DC: Risk Assessment Forum, United States Environmental Protection Agency (U.S. EPA).
  • U.S. EPA. (September 2011). Exposure Factors Handbook 2011 Edition (Final). EPA/600/R-09/052F. Washington, DC: United States Environmental Protection Agency (U.S. EPA).
  • U.S. EPA. (October 2003). Final Draft: Technical Support Document for a Protocol to Assess Asbestos-Related Risk. Prepared for: Office of Solid Waste and Emergency Response. EPA #9345.4-06. Washington, DC: United States Environmental Protection Agency (U.S. EPA).
  • U.S. EPA. (September 2008).Framework for Investigating Asbestos-Contaminated Superfund Sites. OSWER Directive #9200.0-68: Asbestos Committee of the Technical Review Workgroup of the Office of Solid Waste and Emergency Response, United States Environmental Protection Agency (U.S. EPA).
  • U.S. EPA. (2012a). Integrated Risk Information System. Asbestos (CASRN 1332-21-4). Available at: http://www.epa.gov/iris/subst/0371.htm#revhis. File first on-line: 09/26/1988. Carcinogenicity assessment last revised: 07/01/1993. Last updated: 08/09/2012.
  • U.S. EPA. (May 19, 1976).Interim Procedures and Guidelines for Health Risk and Economic Impact Assessments of Suspected Carcinogens. Washington, DC: United States Environmental Protection Agency (U.S. EPA).
  • U.S. EPA. (October 1994). Methods for Derivation of Inhalation Reference Concentrations (RfCs) and Application of Inhalation Dosimetry. EPA/600/8–90/066F. Washington, DC: United States Environmental Protection Agency (U.S. EPA), Office of Research and Development, Office of Health and Environmental Assessment.
  • U.S. EPA. (July 12, 2010). OMB Staff Working Comments on EPA's Toxicological Review of Hydrogen Cyanide and Cyanide Salts and draft IRIS Summary (dated June 2010). Washington, DC: United States Environmental Protection Agency (U.S. EPA).
  • U.S. EPA. (June 12, 2008).Proposed Approach for Estimation of Bin-Specific Cancer Potency Factors for Inhalation Exposure to Asbestos. Draft Report. United States Environmental Protection Agency (U.S. EPA), Office of Solid Waste and Emergency Response.
  • U.S. EPA. (May 2010). Record of Decision for Libby Asbestos Superfund Site. The Former Export Plant Operable Unit 1. Lincoln County, Montana. Washington, DC: United States Environmental Protection Agency (U.S. EPA).
  • U.S. EPA. (December 2002). A Review of the Reference Dose and Reference Concentration Processes. EPA/630/P-02/00F. Final Report. Prepared for the Risk Assessment Forum. Washington, DC: United States Environmental Protection Agency (U.S. EPA).
  • U.S. EPA. (February 9, 2009). Summary of Outdoor Ambient Air Monitoring for Asbestos at the Libby Asbestos Site, Libby, Montana (October 2006 to June 2008). Denver, CO: U.S. Environmental Protection Agency (U.S. EPA), Region 8, Denver, CO, with Technical Assistance from SRC, Denver, CO.
  • U.S. EPA. (2010). Technology Transfer Network. 1996 National-Scale Air Toxics Assessment. Frequently Asked Questions. Available at: http://www.epa.gov/ttnatw01/nata/natsafaq.html#B3. Last updated: 04/15/2010.
  • U.S. EPA. (August 2011).Toxicological Review of Libby Amphibole Asbestos. In Support of Summary Information on the Integrated Risk Information System (IRIS). External Review Draft. Washington, DC: United States Environmental Protection Agency (U.S. EPA).
  • U.S. EPA. (2013b). Vocabulary Catalog List Detail - Integrated Risk Information System (IRIS) Glossary. Available at: http://ofmpub.epa.gov/sor_internet/registry/termreg/searchandretrieve/glossariesandkey wordlists/search.do?details = &glossaryName = IRIS%20Glossary. Last updated: 08/09/2013.
  • Van Cleemput J, De Raeve H, Verschakelen JA, Rombouts J, Lacquet LM, Nemery B. (2001). Surface of localized pleural plaques quantitated by computed tomography scanning: no relation with cumulative asbestos exposure and no effect on lung function. Am J Respir Crit Care Med, 163, 705–10.
  • Venzon DJ, Moolgavkar SH. (1988). A method for computing profile-likelihood-based confidence intervals. Appl Stat, 37, 87–94.
  • Vlaanderen J, Portengen L, Schuz J, Olsson A, Pesch B, Kendzia B, et al. (2014). Effect modification of the association of cumulative exposure and cancer risk by intensity of exposure and time since exposure cessation: a flexible method applied to cigarette smoking and lung cancer in the SYNERGY study. Am J Epidemiol, 179, 290–8.
  • Wang XR, Yano E, Wang M, Wang Z, Christiani DC. (2001). Pulmonary function in long-term asbestos workers in China. J Occup Environ Med, 43, 623–9.
  • Weill D, Dhillon G, Freyder L, Lefante J, Glindmeyer H. (2011). Lung function, radiological changes and exposure: analysis of ATSDR data from Libby, MT, USA. Eur Respir J, 38, 376–83.
  • Weiss W, Levin R, Goodman L. (1981). Pleural plaques and cigarette smoking in asbestos workers. J Occup Med, 23, 427–30.
  • Weiss W, Theodos PA. (1978). Pleuropulmonary disease among asbestos workers in relation to smoking and type of exposure. J Occup Med, 20, 341–5.
  • Weinberg CR, Umbach DM, Greenland S, Weinberg, et al. (1995). Am J Epidemiol, 142, 784.
  • WTO. (September 18, 2000). European Communities – Measures Affecting Asbestos and Asbestos-Containing Products. Report of the Panel. WT/DS135/R. Geneva: World Trade Organization (WTO).
  • Zitting AJ, Karjalainen A, Impivaara O, Kuusela T, Maki J, Tossavainen A, Jarvisalo J. (1996). Radiographic small lung opacities and pleural abnormalities in relation to smoking, urbanization status, and occupational asbestos exposure in Finland. J Occup Environ Med, 38, 602–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.